Zhibin Ye

Zhibin Ye


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WHWei Hong
Wei Hong
QCQun Cheng
Qun Cheng
XZXiaoying Zhu
Xiaoying Zhu
HZHanmin Zhu
Hanmin Zhu
HLHuilin Li
Huilin Li
ZYZhibin Ye
Zhibin Ye
Sarcopenia might be associated with bone fragility in elderly individuals. This study aimed to investigate the prevalence of sarcopenia and its association with fragility fracture sites in elderly Chinese patients. Patients (322 men and 435 women) aged 65–94 years and with a history of fragility fractures in the ankle, wrist, vertebrae or hip, and healthy men (n = 1263) and women (n = 1057) aged 65–92 years without a history of fractures were enrolled. Whole-body dual energy X-ray absorptiometry was used to analyze skeletal muscle mass index (SMI), fat mass and bone mineral density. Sarcopenia was defined as SMI less than two standard deviations below the mean of a young reference group. Sarcopenia occurrence varied with fracture location. Sarcopenia was more common in females with vertebral and hip fractures and in men with hip and ankle fractures than in the non-fracture group). Sarcopenia was significantly more prevalent in men with wrist, hip and ankle fractures than in women. SMI was correlated with BMD in different fracture groups. Logistic regression analyses revealed that lower SMI was associated with an increased risk of hip fracture both in men and women and ankle fracture in men. Sarcopenia may be an independent risk factor for hip and ankle fractures in men, and for hip fractures in women.

1 August 2015 in Molecular Immunology
Verified
Journal Article
Closed access
JXJing Xiao
Jing Xiao
CFChensheng Fu
Chensheng Fu
XZXiaoli Zhang
Xiaoli Zhang
DZDingyu Zhu
Dingyu Zhu
WCWeijun Chen
Weijun Chen
ZYZhibin Ye
Zhibin Ye

6 August 2020 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
WHWei Hong
Wei Hong
ZWZhanying Wei
Zhanying Wei
ZQZhaohui Qiu
Zhaohui Qiu
ZLZheng Li
Zheng Li
CFChensheng Fu
Chensheng Fu
XXxiaoya xu
xiaoya xu
Background: Statins are the most widely used drugs in elderly patients; the most common clinical application of statins is in aged hyperlipemia patients. There are few studies on the effects and mechanisms of statins on bone in elderly mice with hyperlipemia. The study is to examine the effects of atorvastatin on bone phenotypes and metabolism in aged apolipoprotein E-deficient (apoE–/–) mice, and the possible mechanisms involved in these changes.Methods: Twenty-four 60-week-old apoE–/–mice were randomly allocated to two groups. Twelve mice were orally gavaged with atorvastatin (10 mg/kg body weight/day) for 12 weeks; the others served as the control group. Bone mass and skeletal microarchitecture were determined using micro-CT. Bone metabolism was assessed by serum analyses, qRT-PCR, and Western blot. Bone marrow-derived mesenchymal stem cells (BMSCs) from apoE–/–mice were differentiated into osteoblasts and treated with atorvastatin and silent information regulator 1 (Sirt1) inhibitor EX-527.Results: The results showed that long-term administration of atorvastatin increases bone mass and improves bone microarchitecture in trabecular bone but not in cortical bone. Furthermore, the serum bone formation marker osteocalcin (OCN) was ameliorated by atorvastatin, whereas the bone resorption marker tartrate-resistant acid phosphatase 5b (Trap5b) did not appear obviously changes after the treatment of atorvastatin. The mRNA expression of Sirt1, runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and OCN in bone tissue were increased after atorvastatin administration. Western blot showed same trend in Sirt1 and Runx2. The in vitro study showed that when BMSCs from apoE–/–mice were pretreated with EX527, the higher expression of Runx2, ALP, and OCN activated by atorvastatin decreased significantly or showed no difference compared with the control. The protein expression of Runx2 showed same trend.Conclusions: Accordingly, the current study validates the hypothesis that atorvastatin can increase bone mass and promote osteogenesis in aged apoE−/−mice by regulating the Sirt1–Runx2 axis.

29 July 2015 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
WHWei Hong
Wei Hong
SHShasha Hu
Shasha Hu
JZJianan Zou
Jianan Zou
JXJing Xiao
Jing Xiao
XZXiaoli Zhang
Xiaoli Zhang
ZYZhibin Ye
Zhibin Ye
Recent evidence showed that peroxisome proliferator‑activated receptor γ (PPARγ) ameliorates a variety of inflammatory conditions. The present study aimed to investigate the role of PPARγ in regulating NOD-like receptor family, pyrin domain containing 3 (NALP3) inflammasome and interleukin (IL)‑1β levels during monosodium urate (MSU) crystal‑induced inflammation. HK‑2 cells were incubated with or without 200 µg/ml MSU crystals, and mRNA and protein levels of PPARγ were determined using reverse transcription quantitative polymerase chain reaction and western blot analysis, respectively. To verify the role of PPARγ, HK‑2 cells were pre‑treated with PPARγ agonist pioglitazone, and the levels of NALP3 inflammasome and IL‑1β were detected by western blot analysis and ELISA. The results showed that MSU crystals increased PPARγ expression in HK‑2 cells at 24 h, while the expression decreased to normal levels at 48 h. It was also demonstrated that although the PPARγ agonist pioglitazone did not alter the mRNA and protein levels of PPARγ, it significantly reduced the MSU crystal‑induced production of NALP3 inflammasome and IL‑1β in HK‑2 cells, possibly by increasing the level of PPARγ activity. In conclusion, the results of the present study indicated that PPARγ prevented NALP3 inflammasome formation and IL‑1β production in HK‑2 cells stimulated by MSU crystals, which indicated that PPARγ may represent a novel target for the treatment of hyperuricemic nephropathy.

21 January 2019 in International Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
QYQingmei Yang
Qingmei Yang
CFChensheng Fu
Chensheng Fu
XZXiaoli Zhang
Xiaoli Zhang
ZZZhenxing Zhang
Zhenxing Zhang
JZJianan Zou
Jianan Zou
ZYZhibin Ye
Zhibin Ye
Adiponectin (APN) exerts anti-inflammatory effects in various cells. Uric acid (UA) induces inflammation in proximal renal tubular epithelial cells (PTECs). It remains unknown whether APN protects against UA-induced inflammation. In the present study, human PTECs were incubated with 100 mu g/ml soluble (S) UA in the presence or absence of globular (g) APN, APN receptor 1 (AdipoR1)-short hairpin RNA lentivirus or compound C. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays were performed to assess APN mRNA expression. Immunoblotting was used to assess the protein expression of APN, AdipoR1, NACHT, leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) and the activation of tumor necrosis factor (TNF) and adenosine monophosphate-activated protein kinase (AMPK). ELISA analyses were performed to assess supernatant levels of interleukin (IL)-1 and TNF. It was observed that SUA significantly enhanced APN mRNA and protein expression (both P<0.05) and increased NLRP3 (P<0.001) and TNF (P<0.05) protein levels, as well as supernatant levels of IL-1 (P<0.01) and TNF (P<0.001) compared with untreated cells. gAPN administration significantly limited TNF synthesis and secretion (both P<0.001), significantly decreased IL-1 release (P<0.01), impacted NLRP3 protein expression and augmented AdipoR1 protein (P<0.01) and AMPK phosphorylation (P<0.05) levels compared with SUA-treated cells. AdipoR1 knockdown significantly promoted the synthesis (P<0.05) and release of TNF (P<0.001), significantly increased IL-1 supernatant levels (P0.05) compared with the SUA-treated cells. Secreted TNF levels were significantly increased upon the inhibition of AMPK (P0.05). In summary, the data demonstrated that SUA promoted APN expression in PTECs and that gAPN attenuated SUA-induced inflammation through the AdipoR1/AMPK signaling pathway. AdipoR1 knockdown and AMPK inactivation increased SUA-induced inflammatory damage in PTECs. These findings may help to further understand and regulate UA-associated inflammation in proximal renal tubules.

7 April 2023 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
KLKaixin Li
Kaixin Li
JZJiaxi Zhao
Jiaxi Zhao
WYWenjing Yang
Wenjing Yang
ZYZhibin Ye
Zhibin Ye
Background: Epidemiological evidence relating sleep disorders to end-stage renal disease (ESRD) has been obscure. The present study is sought to examine the association between sleep traits and ESRD.Methods: For this analysis, we selected genetic instruments for sleep traits from published genome-wide association studies (GWAS). As instrumental variables, independent genetic variations linked with seven sleep-related features (sleep duration, getting up in the morning, daytime napping, chronotype of morning/evening person, sleeplessness/insomnia, non-snoring, and daytime dozing) were chosen. A two-sample Mendelian randomization (TSMR) study was conducted to assess the causal relationship between sleep traits and ESRD (N = 33,061). The reverse MR analysis subsequently determined the causal relationship between ESRD and sleep traits. The causal effects were estimated using inverse variance weighted, MR-Egger, weighted median. To conduct sensitivity studies, Cochran’s Q test, MR-Egger intercept test, MR-PRESSO, leave-one-out analysis, and funnel plot were used. To study the potential mediators, multivariable mendelian randomization analyses were undertaken further.Results: Genetically predicted sleeplessness/ insomnia (OR = 6.11, 95%CI 1.00-37.3, P = 0.049, FDR = 0.105), getting up in the morning easily(OR = 0.23, 95%CI 0.063–0.85; P = 0.0278, FDR = 0.105), non-snoring (OR = 4.76E-02, 95%CI 2.29E-03-0.985, P = 0.0488, FDR = 0.105) was suggestively associated with the risk of ESRD. However, we found no evidence favoring a causal association between other sleep traits and ESRD through the IVW method.Conclusion: The present TSMR found no strong evidence of a bidirectional causal association between genetically predicted sleep traits and ESRD.